Procter & Gamble Health Ltd
NSE:PGHL
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Procter & Gamble Health Ltd
NSE:PGHL
|
85.9B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.2B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.3B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.4B USD |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Procter & Gamble Health Ltd
Glance View
In the vast landscape of healthcare, Procter & Gamble Health Ltd. carves its niche by blending science with daily life, transforming mundane routines into healthier lifestyles. Originally known for its parent company’s deep roots in consumer goods, P&G Health Ltd. has transitioned seamlessly into the pharmaceutical domain, focusing on over-the-counter (OTC) health products and supplements. Its journey is one of leveraging brand trust and an extensive distribution network to ensure that essential health solutions are accessible to consumers around the globe. P&G Health's emphasis on consumer awareness and education propels its growth, as it capitalizes on the modern consumer’s desire for self-care and proactive health management. At the heart of its business model lies a portfolio of products that spans various health categories, encapsulating vitamins, minerals, and supplements that address widespread health needs such as digestive wellness and immunity. The company thrives on innovation and strategic collaboration, utilizing a mix of in-house research alongside partnerships to remain at the forefront of consumer health trends. Revenue streams are buoyed by the strength of its established global market presence and regional expertise, ensuring adaptability across diverse economic landscapes. By catering to both established and emerging markets, Procter & Gamble Health Ltd. sustains its growth momentum, continuously refining its product offerings to meet the dynamic demands of health-conscious consumers.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Procter & Gamble Health Ltd is 32.5%, which is above its 3-year median of 26.3%.
Over the last 3 years, Procter & Gamble Health Ltd’s Operating Margin has increased from 22.3% to 32.5%. During this period, it reached a low of 22.3% on Sep 30, 2022 and a high of 32.6% on Mar 31, 2025.